Everardo Cuevas-Espinoza
Nurse Practitioner · Ringgold, VANPI 1760952857
Payments from drug & device makers
Across 154 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$440
- Lilly USA, LLC$358
- Novo Nordisk$357
- Otsuka America Pharmaceutical, Inc.$189
- AstraZeneca$140
- Merck$129
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,666100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 27 | $440 |
| Lilly USA, LLC | 20 | $358 |
| Novo Nordisk | 20 | $357 |
| Otsuka America Pharmaceutical, Inc. | 9 | $189 |
| AstraZeneca | 10 | $140 |
| Merck | 9 | $129 |
| Boehringer Ingelheim | 6 | $108 |
| Pfizer | 6 | $104 |
| E.r. Squibb & Sons, L.L.C. | 5 | $94 |
| Johnson & Johnson | 4 | $65 |
| Sanofi-aventis U.S. LLC | 3 | $64 |
| Exact Sciences | 3 | $57 |
| Amgen | 4 | $54 |
| Bayer | 3 | $54 |
| Corcept Therapeutics | 2 | $50 |
| Lundbeck LLC | 2 | $44 |
| GSK | 2 | $38 |
| Corium, LLC | 2 | $36 |
| Sanofi Pasteur Inc. | 2 | $33 |
| Organon | 1 | $32 |
| Xeris Pharmaceuticals, Inc. | 2 | $31 |
| Biohaven Pharmaceuticals, Inc. | 2 | $27 |
| Hikma Pharmaceuticals USA | 2 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
How this compares
$2,666 in reported general payments places this provider in the 90th percentile of 2,166 nurse practitioner providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 98 | $106,049 |
| OzempicSemaglutide | 62 | $95,052 |
| MounjaroTirzepatide | 34 | $46,259 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 64 | $42,464 |
| Nurtec OdtRimegepant Sulfate | 19 | $37,514 |
| EliquisApixaban | 29 | $37,309 |
| JardianceEmpagliflozin | 16 | $20,120 |
| LinzessLinaclotide | 13 | $19,749 |
| TrulicityDulaglutide | 17 | $18,797 |
| WegovySemaglutide | 11 | $17,934 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 21 | $10,977 |
| Repatha SyringeEvolocumab | 16 | $8,822 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $7,578 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 33 | $7,348 |
| Lurasidone Hcl | 28 | $6,923 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Wegovy | $357 | $112,98773 claims |
| AstraZenecaFarxiga | $140 | $106,04998 claims |
| PfizerNurtec Odt, Eliquis | $104 | $74,82348 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Shingrix, Arexvy, Incruse Ellipta | $38 | $70,835148 claims |
| Lilly USA, LLCMounjaro, Trulicity | $358 | $65,05651 claims |
| Boehringer IngelheimJardiance, Tradjenta | $108 | $26,17528 claims |
| AbbVieLinzess | $440 | $19,74913 claims |
| MerckBelsomra | $129 | $6,34415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,166 nurse practitioner providers in Virginia.
Other nurse practitioner in Ringgold
- Samantha FoxGate City$207K
- Mikel GrayCharlottesville$174K
- Kevin BrigleRichmond$166K
- Denese GomesRichmond$126K
- Ashley CarmenAlexandria$99K
- Rachel AndersonCharlottesville$90K
- Megan FrancisArlington$81K
- Elizabeth WilletteNorfolk$58K
- Lacey LyleSuffolk$50K
- Sasha LeeVirginia Beach$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.